181 related articles for article (PubMed ID: 12749516)
21. Hospitalized low-risk community-acquired pneumonia: outcome and potential for cost-savings.
Hoe LK; Keang LT
Respirology; 1999 Sep; 4(3):307-9. PubMed ID: 10489681
[TBL] [Abstract][Full Text] [Related]
22. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
23. [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia].
Pişkin N; Aydemir H; Oztoprak N; Akduman D; Celebi G; Seremet Keskin A
Mikrobiyol Bul; 2009 Oct; 43(4):597-606. PubMed ID: 20084912
[TBL] [Abstract][Full Text] [Related]
24. Hospitalization for Community-Acquired Pneumonia in Children: Effect of an Asthma Codiagnosis.
Wilson KM; Torok MR; Localio R; McLeod L; Srivastava R; Luan X; Mohamad Z; Shah SS;
Hosp Pediatr; 2015 Aug; 5(8):415-22. PubMed ID: 26231631
[TBL] [Abstract][Full Text] [Related]
25. Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.
Attridge RT; Frei CR; Pugh MJ; Lawson KA; Ryan L; Anzueto A; Metersky ML; Restrepo MI; Mortensen EM
J Crit Care; 2016 Dec; 36():265-271. PubMed ID: 27595461
[TBL] [Abstract][Full Text] [Related]
26. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
Samsa GP; Matchar DB; Harnett J; Wilson J
Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
[TBL] [Abstract][Full Text] [Related]
27. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis.
Spoorenberg SM; Bos WJ; Heijligenberg R; Voorn PG; Grutters JC; Rijkers GT; van de Garde EM
BMC Infect Dis; 2014 Jun; 14():335. PubMed ID: 24938861
[TBL] [Abstract][Full Text] [Related]
28. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
29. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
[TBL] [Abstract][Full Text] [Related]
31. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.
Arnold FW; Wiemken TL; Peyrani P; Ramirez JA; Brock GN;
Respir Med; 2013 Jul; 107(7):1101-11. PubMed ID: 23660396
[TBL] [Abstract][Full Text] [Related]
32. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.
Kaplan V; Angus DC; Griffin MF; Clermont G; Scott Watson R; Linde-Zwirble WT
Am J Respir Crit Care Med; 2002 Mar; 165(6):766-72. PubMed ID: 11897642
[TBL] [Abstract][Full Text] [Related]
33. Implementing a standardized order set for community-acquired pneumonia: impact on mortality and cost.
Fleming NS; Ogola G; Ballard DJ
Jt Comm J Qual Patient Saf; 2009 Aug; 35(8):414-21. PubMed ID: 19719077
[TBL] [Abstract][Full Text] [Related]
34. Economic cost of community-acquired pneumonia in New Zealand adults.
Scott G; Scott H; Turley M; Baker M
N Z Med J; 2004 Jun; 117(1196):U933. PubMed ID: 15280937
[TBL] [Abstract][Full Text] [Related]
35. A population-based study of the costs of care for community-acquired pneumonia.
Bartolomé M; Almirall J; Morera J; Pera G; Ortún V; Bassa J; Bolíbar I; Balanzó X; Verdaguer A;
Eur Respir J; 2004 Apr; 23(4):610-6. PubMed ID: 15083763
[TBL] [Abstract][Full Text] [Related]
36. Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals.
Marras TK; Jamieson L; Chan CK
Can Respir J; 2004 Mar; 11(2):131-7. PubMed ID: 15045044
[TBL] [Abstract][Full Text] [Related]
37. Private costs of patients hospitalized with community-acquired pneumonia.
Jacobs P; Marrie TJ; Calder P
Can Respir J; 2005; 12(4):205-8. PubMed ID: 16003457
[TBL] [Abstract][Full Text] [Related]
38. Gaps between current clinical practice and evidence-based guidelines for treatment and care of older patients with Community Acquired Pneumonia: a descriptive cross-sectional study.
Eekholm S; Ahlström G; Kristensson J; Lindhardt T
BMC Infect Dis; 2020 Jan; 20(1):73. PubMed ID: 31973742
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
[TBL] [Abstract][Full Text] [Related]
40. Impact of prior pulmonary tuberculosis in treatment outcomes of HCAP and CAP patients in intensive care units.
Lin FM; Feng JY; Fang WF; Wu CL; Yu CJ; Lin MC; Ku SC; Chen CW; Tu CY; Yang KY
J Microbiol Immunol Infect; 2019 Apr; 52(2):320-328. PubMed ID: 30245205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
